Interpretation of IST and CAST stroke trials (multiple letters) [9]

Lancet

Volumn 350, Issue 9075, 1997, Pages 440-444

  Barer, D ^a   Cohen, A ^a   Bradford, A P ^a   Khan, S A ^a   Lees, K R ^a   McInnes, G T ^a   Semple, P F ^a   Ricci, S ^a   Cantisani, T A ^a   Grazia Celani, C ^a   Righetti, E ^a   Chen, Z ^a   Collins, R ^a   Peto, R ^a   Xie, J X ^a   Lhi, L S ^a   Brousser, M G ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN; STATIN;

BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; HEART ATRIUM FIBRILLATION; HUMAN; LETTER; PRIORITY JOURNAL; STROKE; BLOOD CLOTTING; CEREBROVASCULAR DISEASE; DRUG EFFECT; NOTE; THROMBOSIS; HOSPITALIZATION; MORTALITY; PROGNOSIS;

ANTICOAGULANTS; BLOOD COAGULATION; CEREBROVASCULAR DISORDERS; HEPARIN; HUMANS; THROMBOSIS; ASPIRIN; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

MLCS; MLOWN;

EID: 85046172835     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)26032-0     Document Type: Letter

References (0)